AQR Capital Management
RUBY

AQR Capital Management’s Rubius Therapeutics, Inc RUBY Stock Holding History

AQR Capital Management’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-164,161
Closed -$140K – 2372
2022
Q2 		$140K Buy
+164,161
New +$276K ﹤0.01% 2049
2022
Q1 		– Sell
-17,211
Closed -$167K – 2324
2021
Q4 		$167K Sell
17,211
-10,495
-38% -$146K ﹤0.01% 2110
2021
Q3 		$495K Sell
27,706
-15,359
-36% -$334K ﹤0.01% 1870
2021
Q2 		$1.05M Buy
+43,065
New +$1.08M ﹤0.01% 1569

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

AQR Capital Management's RUBY Position: Q3 2022 in Review

AQR Capital Management sold out of Rubius Therapeutics, Inc (RUBY) in Q3 2022, closing a stake of 164,161 shares — an estimated $140K sold.

AQR Capital Management first reported a position in RUBY in Q2 2021 and held it in 4 quarters. The position peaked at $1.05M in Q2 2021. 62 funds tracked by Wall St. Rank hold RUBY as of Q3 2022.

  • AQR Capital Management reported no remaining Rubius Therapeutics, Inc position as of Q3 2022 after selling out during the quarter.
  • AQR Capital Management sold 164,161 Rubius Therapeutics, Inc shares in Q3 2022, an estimated $140K.
  • AQR Capital Management first reported a position in Rubius Therapeutics, Inc in Q2 2021 and held it in 4 quarters.
  • AQR Capital Management's Rubius Therapeutics, Inc position peaked at $1.05M in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q3 2022.

Based on AQR Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.